FDA Approves Kyzatrex (testosterone undecanoate) for the Treatment of Male Hypogonadism

RALEIGH, N.C., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company, today announced the approval of Kyzatrex (testosterone undecanoate) by the U.S. Food and Drug Administration (FDA). Kyzatrex is an oral...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news